Clinical Toxicology of Drugs Used in the Treatment of Opiate Dependency

Anggard, 1979, Pharmacokinetics of methadone during maintenance therapy: Pulse labelling with deuterated methadone in the steady state, Eur J Clin Pharmacol, 16, 53, 10.1007/BF00644967

Arndts, 1981, Development of an ria for clonidine and its comparison with the reference methods, J Pharmacol Method, 6, 295, 10.1016/0160-5402(81)90069-3

Beckett, 1968, The biotransformation of methadone in man: Synthesis and identification of a major metabolite, J Pharm Pharmacol, 20, 754, 10.1111/j.2042-7158.1968.tb09634.x

Bell ward, 1977, Methadone maintenance: Effect of urinary pH on renal clearance in chronic high and low doses, Clin Pharmacol Ther, 22, 92, 10.1002/cpt197722192

Billings, 1974, 1-Acetylmethadol (LAM) treatment of opiate dependence: Plasma and urine levels of two pharmacologically active metabolites, LifeSci, 14, 1437, 10.1016/0024-3205(74)90154-4

Cami, 1985, Efficacy of clonidine and of methadone in the rapid detoxification of patients dependent on heroin, Clin Pharmacol Ther, 38, 336, 10.1038/clpt.1985.182

Cone, 1984, The metabolism and excretion of buprenorphine in humans, Drug Metab Dispos, 12, 577

Cone, 1978, The identification and measurement of two new metabolites of naltrexone in human urine, Res Common Chem Pathol Pharmacol, 20, 413

Crabtree, 1984, Review of naltrexone, a long-acting opiate antagonist, Clin Pharmacol, 3, 273

Dole, 1973, Methadone plasma level: Sustained by a reservoir of drug in tissue, Proc Natl Acad Sci USA, 70, 10, 10.1073/pnas.70.1.10

Edlund, 1980, Determination of clonidine in human plasma by glass capillary gas chromatography with electron capture detection, J Chromatogr, 187, 161, 10.1016/S0021-9673(00)87882-6

Garrett, 1985, Pharmacokinetic investigations of drugs of abuse, 1

Goldstein, 1976, LAAM and LAAM metabolites: Plasma levels in patients. Summary progress report, NIDA Research Monograph Series No. 8, 61

Hedel, 1979, Buprenorphine: A review of its pharmacological properties and therapeutic efficacy, Drugs, 17, 81, 10.2165/00003495-197917020-00001

Henderson, 1976, Pharmacodynamics of LAAM in man: Plasma levels of LAAM and its metabolites following acute and chronic administration in man, NIDA Research Monograph Series No. 8, 64

Henderson, 1977, Plasma 1-alpha methadol (LAAM) after acute and chronic administration, Clin Pharmacol Ther, 21, 16, 10.1002/cpt197721116

Holmstrand, 1978, Methadone maintenance: Plasma levels and therapeutic outcome, Clin Pharmacol Ther, 23, 175, 10.1002/cpt1978232175

Judson, 1981, Naltrexone treatment of heroin addiction: Efficacy and safety in a double blind dosage comparison, Drug Alcohol Depend, 7, 325, 10.1016/0376-8716(81)90049-1

Kreek, 1980, Effects of liver disease on urinary excretion of methadone and metabolites in maintenance patients: Quantitation by direct probe chemical ionization mass spectrometry, Biomed Mass Spectrom, 7, 385, 10.1002/bms.1200070906

Lowenthal, 1980, Pharmacokinetics of clonidine, J Cardiovasc Pharmacol, 2, 529, 10.1097/00005344-198000021-00004

Ling, 1976, Methadyl acetate and methadone as maintenance treatments for heroin addicts, Arch Gen Psychiatry, 33, 709, 10.1001/archpsyc.1976.01770060043007

Ling, 1978, A cooperative clinical study of methadyl acetate: I. Three times a week regimen, Arch Gen Psychiatry, 35, 345, 10.1001/archpsyc.1978.01770270095009

Louis, 1983, Relationship of immunoassayable clonidine plasma levels to its pharmacologic action in clinical and experimental hypertension, Chest, 83, 352, 10.1378/chest.83.2_Supplement.352

Murray, 1981, The measurement of clonidine in human plasma and urine by combined gas chromatography-mass spectrometry with ammonia chemical ionization, Biomed Mass Spectrom, 8, 500, 10.1002/bms.1200081007

Murray, 1984, Bis(trifluoromethyl) aryl derivatives for drug analysis by gas chromatography electron capture negative ion chemical ionization mass spectrometry. Application to the measurement of low levels of clonidine in plasma, Biomed Mass Spectrom, 11, 435, 10.1002/bms.1200110813

Nilsson, 1982, Effect of urinary pH on the disposition of methadone in man, Eur J Clin Pharmacol, 22, 337, 10.1007/BF00548403

Novick, 1985, Effects of severe alcoholic liver disease on the disposition of methadone in maintenance subjects, Alcoholism Clin Exp Res, 9, 349, 10.1111/j.1530-0277.1985.tb05558.x

Olsen, 1973, Methadone binding to human plasma protein, Clin Pharmacol Ther, 14, 338, 10.1002/cpt1973143338

Pohland, 1971, Synthesis and identification of metabolites resulting from the biotransformation of d, 1-methadone in man and in the rat, J Med Chem, 14, 194, 10.1021/jm00285a004

Rawson, 1981, Clonidine hydrochloride detoxification from methadone treatments: The value of naltrexone aftercare, NIDA Research Monograph Series No. 34, 101

Resnick, 1985, Methadone, LAAM, naltrexone and cocaine: Clinical pharmacodynamics and treatment issues, 264

Resnick, 1976, Studies of naltrexone: A new narcotic antagonist, Am J Psychiatry, 131, 646, 10.1176/ajp.131.6.646

Romach, 1981, Methadone binding to oroscomucoid (alpha-1-acid glycoprotein): Determinant of free fraction in plasma, Clin Pharmacol Ther, 29, 211, 10.1038/clpt.1981.34

Sollod, 1976, Clinical studies—phase I, NIDA Research Monograph Series No. 8, 39

Sullivan, 1972, The identification of three new metabolites of methadone in man and in the rat, J Am Chem Soc, 94, 4050, 10.1021/ja00766a086

Tennant, 1986, Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM), J Subst Abuse Treat, 3, 195, 10.1016/0740-5472(86)90021-8

Valasquez, 1983, Plasma clonidine levels in hypertension, Clin Pharmacol Ther, 34, 341, 10.1038/clpt.1983.177

Verebey, 1980, Quantitative determination of 2-hydroxy-3-methoxy-6-beta naltrexol (HMN), naltrexone, and 6-beta naltrexol in human plasma, red blood cells, saliva, and urine by gas liquid chromatography, J Anal Toxicol, 4, 33, 10.1093/jat/4.1.33

Verebey, 1980, Quantitative determination of naltrexone, 6-beta naltrexol and 2-hydroxy-3-methoxy-6-beta naltrexol (HMN) in human plasma, red blood cells, saliva, and urine by gas liquid chromatography, NIDA Research Monograph Series No. 28, 36

Verebey, 1975, Methadone plasma levels in maintenance patients: The effect of dose omission, Res Commun Chem Pathol Pharmacol, 11, 373

Way EL, Alder TK: The biological disposition of morphine and its surrogates. WHO Bull Geneva, 1982

Zanguell, 1986, How effective is LAAM treatment? Clinical comparison with methadone, NIDA Research Monograph Series No. 67, 249